Silo Pharma Inc (SILO) — Cash Flow Quality Index
Latest as of June 2025:
-1.25x
Silo Pharma Inc (SILO) has a Cash Flow Quality Index of -1.25x as of June 2025. Operating cash flow of $-1.29 Million is below net income of $1.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Silo Pharma Inc (SILO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-1.25x
Operating CF / Net Income
Operating Cash Flow
$-1.29 Million
USD
Net Income
$1.03 Million
USD
Data as of
Jun 2025
Most recent filing
Silo Pharma Inc Cash Flow Quality Index (2013–2021)
Historical Cash Flow Quality Index for Silo Pharma Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Silo Pharma Inc.
Annual Cash Flow Quality Index for Silo Pharma Inc (2013–2021)
Year-by-year earnings quality comparison for Silo Pharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.55x | $-2.28 Million | $4.16 Million | ▲ +31.4% |
| 2017 | -0.80x | $-284.62K | $356.54K | ▲ +85.5% |
| 2013 | -5.52x | $-181.61K | $32.91K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.